Fintel reports that on September 25, 2025, RBC Capital initiated coverage of Apogee Therapeutics (NasdaqGM:APGE) with a Outperform recommendation. Analyst Price Forecast Suggests 159.85% Upside As of ...

This year's Oktoberfest is well underway in Germany but the celebrations are no longer only limited to Munich. The annual ...

Aetrex has expanded on its leading foot scanning technology for its kids' shoe fitting platform with the launch of its ...

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the ...

Gilead Sciences (GILD) concluded the recent trading session at $110.99, signifying a -2.36% move from its prior day's close.

Axon Enterprise's Q2 2025 revenue rose 33% YoY to $669 million, with SaaS revenue up 39% and management raising 2025 guidance ...

A new Elusive Target mission will go live soon in Hitman: World of Assassination, and this time, Agent 47 will be teaming up with the legendary martial artist Bruce Lee to take down his mark. The ...

Barclays’ latest report argues that raising SME investment to the same level as larger firms could unlock an additional £60 billion annually f ...